New Dimensions Health Fund makes debut investment in outpatient radiology firm ELMNT IR
What's the deal? New Dimensions Health (NDH) FundDealroom has a profile for this one. Try Dealroom → has announced its first investment in ELMNT IR, a Los Angeles-based company building a multi-site outpatient interventional radiology business. NDH Fund focuses on $50–$250M investments in early-stage and growth-oriented healthcare companies.
ELMNT IR was co-founded by Steven Yecies, who also founded and manages NDH Fund, alongside chief medical officer Jonathan Steinberger. The company aims to shift interventional radiology procedures from costly inpatient hospital settings to outpatient clinics, reducing prices while improving access.
ELMNT IR currently operates in the Southern California market and is headquartered in Los Angeles.
Why now? Healthcare has been steadily migrating toward ambulatory settings as less invasive technologies make outpatient procedures safer and more practical. Interventional radiology — which uses imaging to guide minimally invasive treatments — is a natural fit for this shift.
"I have been deeply involved in establishing ELMNT IR with my clinical co-founders and am excited about our common vision and rapid growth," Yecies said.
What could go wrong? The most obvious conflict: NDH Fund's founder also co-founded the company it is backing. That intertwined relationship could raise governance questions among outside limited partners, even as Yecies frames it as creating "proprietary investment opportunities."
Scaling multi-site healthcare operations across states is notoriously complex, involving varied regulatory frameworks, licensing requirements, and payer negotiations. ELMNT IR's ambition to become the first meaningful multistate outpatient interventional radiology company means it is charting largely unproven territory.
The signal: The investment reflects two broader trends. First, private capital continues to flow into healthcare services that promise lower costs by moving procedures out of hospitals. Second, speciality-focused clinic rollups remain an attractive thesis for healthcare investors betting on fragmented markets ripe for consolidation.
Yecies brings experience from more than 50 prior healthcare investments at firms including OrbiMed and Kain CapitalDealroom has a profile for this one. Try Dealroom →. Whether that track record translates into a scalable outpatient radiology platform will be the real test for NDH Fund's debut bet.
Read more: EIN Presswire
